Sheets Smith Investment Management’s Anavex Life Sciences AVXL Stock Holding History

Sheets Smith Investment Management’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$1.21M	Buy	+135,948	New	+$1.38M	0.78%	54

Other funds holding AVXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

NWAM LLC Mercer Island, Washington $1.74B AUM 32.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Sheets Smith Investment Management's AVXL Position: Q3 2025 in Review

Sheets Smith Investment Management opened a new position in Anavex Life Sciences (AVXL) in Q3 2025: 135,948 shares worth $1.21M. The stake represents 0.78% of the portfolio and ranks #54 among its holdings.

186 funds tracked by Wall St. Rank hold AVXL as of Q3 2025.

Sheets Smith Investment Management held 135,948 shares of Anavex Life Sciences worth $1.21M as of Q3 2025.
Anavex Life Sciences was a new Sheets Smith Investment Management position in Q3 2025.
Anavex Life Sciences made up 0.78% of Sheets Smith Investment Management's portfolio in Q3 2025, its #54 holding.
186 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2025.

Based on Sheets Smith Investment Management's 13F filing for Q3 2025, filed 8 Oct 2025.